Pan-European dental group Curaeos has reportedly struck a deal with some of its creditors in a move that will lighten the company's debt while transferring a minority stake.
The Netherlands and Belgium are closely following behind Germany in reimbursing digital therapeutics (DTx). Payors in the former are negotiating a strategy while the latter has just seen a rehabilitation app become the first to receive public payment.
Cigna now describes itself as “a global health service company” rather than an insurer and has reorganised its European operations. Toor has recently been promoted to CEO Europe. He says that the insurer, which has 15% (US$840m) of its revenue in Europe, doesn't want to verticalise through owning primary care providers but wants instead to provide an end-to-end user experience.
Netherlands-based elderly tech solutions developer FocusCura has been bought by listed Swedish conglomerate ASSA ABLOY around 18 months after spinning off its telemonitoring app Luscii into a separate subsidiary. The €20bn market-cap 'access solutions' firm is a curious buyer but it tells HBI that the acquisition creates opportunities to develop further products for elderly care.
Dentists in Germany and the Netherlands are playing post-COVID closure catchup as businesses have reopened after the height of the pandemic. One DACH-based operator tells us it may be harder to make up lost ground in these countries than elsewhere.
HBI hears that Dutch and Nordic ambulatory and ophthalmology clinic chain Bergman Clinic is looking to acquire two substantial outpatient ophthalmology chains in Germany. This would mark its entry into the country’s ophthalmology market – and a significant one at that. We talk to a source about the targets, the price, and what this means for the wider market. Longer-term Bergman itself is likely to sell.
Dutch insurers say they will pay for empty beds in nursing homes to prevent them falling into bankruptcy, as COVID-19 has hit the sector hard. HBI talks to an Arnhem-based consultant to find out more.
Regulatory body Public Health England (PHE) has ordered telehealth player Babylon to stop selling B2C antibody tests until it has established their accuracy. Supplier Abbott has already said that the test is not suitable for home sample collection but players are still scrambling to sell in what's likely to be a multi-billion market.
West Europe's for-profit hospital market is set to shrink by at least 10% in 2020 due to the COVID-19 pandemic, according to research done for the HBI Intelligence Centre.
Much of the world’s workforce is sat working from home and many others are out on the frontline, either in hospitals or retail. That is presenting new potential customers for a host of online mental health services across Europe as they seek to plug the gap where the public sector has pulled back. Employers, health care providers and individuals – including children stuck at home – are now bumping up demand.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
